These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28782046)

  • 1. Circulating LOXL
    Seang S; Somasunderam A; Nigalye M; Somsouk M; Schacker TW; Sanchez JL; Hunt PW; Utay NS; Lake JE
    Pathog Immun; 2017; 2(2):239-252. PubMed ID: 28782046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief report: Circulating markers of fibrosis are associated with immune reconstitution status in HIV-infected men.
    Tobolowsky FA; Wada N; Martinez-Maza O; Magpantay L; Koletar SL; Palella FJ; Brown TT; Lake JE
    PLoS One; 2018; 13(1):e0191606. PubMed ID: 29381717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
    Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
    J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
    Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
    Front Immunol; 2021; 12():688886. PubMed ID: 34135912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4
    Zaunders J; Danta M; Bailey M; Mak G; Marks K; Seddiki N; Xu Y; Templeton DJ; Cooper DA; Boyd MA; Kelleher AD; Koelsch KK
    Front Immunol; 2016; 7():438. PubMed ID: 27822211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.
    Evering TH; Mehandru S; Racz P; Tenner-Racz K; Poles MA; Figueroa A; Mohri H; Markowitz M
    PLoS Pathog; 2012 Feb; 8(2):e1002506. PubMed ID: 22319447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.
    Chun TW; Nickle DC; Justement JS; Meyers JH; Roby G; Hallahan CW; Kottilil S; Moir S; Mican JM; Mullins JI; Ward DJ; Kovacs JA; Mannon PJ; Fauci AS
    J Infect Dis; 2008 Mar; 197(5):714-20. PubMed ID: 18260759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV.
    Luo Z; Health SL; Li M; Yang H; Wu Y; Collins M; Deeks SG; Martin JN; Scott A; Jiang W
    EBioMedicine; 2022 Jun; 80():104037. PubMed ID: 35500539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen deposition limits immune reconstitution in the gut.
    Estes J; Baker JV; Brenchley JM; Khoruts A; Barthold JL; Bantle A; Reilly CS; Beilman GJ; George ME; Douek DC; Haase AT; Schacker TW
    J Infect Dis; 2008 Aug; 198(4):456-64. PubMed ID: 18598193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.
    Shacklett BL; Cox CA; Sandberg JK; Stollman NH; Jacobson MA; Nixon DF
    J Virol; 2003 May; 77(10):5621-31. PubMed ID: 12719554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells.
    Verhoeven D; Sankaran S; Silvey M; Dandekar S
    J Virol; 2008 Apr; 82(8):4016-27. PubMed ID: 18272585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment.
    Briceño O; Pinto-Cardoso S; Rodríguez-Bernabe N; Murakami-Ogasawara A; Reyes-Terán G
    PLoS One; 2016; 11(11):e0166496. PubMed ID: 27898686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
    Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.
    Gordon SN; Cervasi B; Odorizzi P; Silverman R; Aberra F; Ginsberg G; Estes JD; Paiardini M; Frank I; Silvestri G
    J Immunol; 2010 Nov; 185(9):5169-79. PubMed ID: 20889546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
    d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
    PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.
    Kamat A; Misra V; Cassol E; Ancuta P; Yan Z; Li C; Morgello S; Gabuzda D
    PLoS One; 2012; 7(2):e30881. PubMed ID: 22363505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection.
    Karris MY; Kao YT; Patel D; Dawson M; Woods SP; Vaida F; Spina C; Richman D; Little S; Smith DM
    AIDS; 2014 Mar; 28(6):841-9. PubMed ID: 24401640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings.
    Shete A; Dhayarkar S; Dhamanage A; Kulkarni S; Ghate M; Sangle S; Medhe U; Verma V; Rajan S; Hattori T; Gangakhedkar R
    AIDS Res Ther; 2020 Jul; 17(1):43. PubMed ID: 32678033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.
    Tincati C; Merlini E; Braidotti P; Ancona G; Savi F; Tosi D; Borghi E; Callegari ML; Mangiavillano B; Barassi A; Bulfamante G; d'Arminio Monforte A; Romagnoli S; Chomont N; Marchetti G
    AIDS; 2016 Apr; 30(7):991-1003. PubMed ID: 27028142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects.
    Shacklett BL; Beadle TJ; Pacheco PA; Grendell JH; Haslett PA; King AS; Ogg GS; Basuk PM; Nixon DF
    Virology; 2000 May; 270(2):317-27. PubMed ID: 10792991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.